Itolizumab Receives Fast Track Status for Lupus Nephritis – Renal and Urology News
The FDA has granted Fast Track designation for itolizumab (EQ001; Equillium) for the treatment of lupus nephritis.
Related Articles
Enzalutamide vs ADT Slows Sexual Decline in Men With Prostate Cancer BCR
Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.
Model Predicts Systemic Inflammatory Response Syndrome After Kidney Stone Surgery
Investigators created a model to identify patients at high-risk for post-operative urosepsis.
SGLT2 Inhibitors May Lower Stone Risk in Patients Regardless of Stone History
This is the first study examining possible SGLT2 inhibitor benefits in recurrent stone formers.
Bone-Protecting Agents Reduce Fracture Rate in mCRPC
Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).
Red Wine No Better Than White in Terms of Cancer Risk
However, white wine significantly associated with increased risk for cancer among women and in analyses restricted to cohort studies
Specific Cancer Types Linked to Dementia Subtypes and Impact of Chemotherapy
There is an inverse bidirectional association between cancer and dementia, a relationship that holds across cancer and dementia subtypes.
Intraoperative Remifentanil, Sufentanil Tied to Poor Postoperative Pain Experience
Other predictors of poor pain experience include American Society of Anesthesiologists 3 status, postoperative anxiolytic use, amnesia
Lorundrostat Beneficial for Patients With Uncontrolled, Resistant Hypertension
Topline data were announced from a phase 3 trial investigating lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension.
SGLT2 Inhibitors Confer Greater Cardioprotective Effect in Older Adults With T2D
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
One-Hour Glucose on OGTT at 3 Months Postpartum Predicts Dysglycemia
One-hour glucose was strongest predictor of dysglycemia on regression analyses, followed by 2-hour glucose